Health Ministry Expands Schedule H2 QR Code Drug Traceability to All Therapeutic Classes

Health Ministry Proposes Mandatory CCTV at Retail Pharmacies for Schedule H, H1, X Drugs with 3-Month Recording Retention

The Health Ministry has proposed mandatory installation of CCTV cameras at retail medical stores to track sale of prescription drugs under Schedules H, H1, and X. Recordings must be preserved for 3 months. This regulatory reform is crucial for students to understand drug classification and governance in the health sector.

Union Health Ministry Mandates CCTV at Medical Stores for Schedule H, H1, X Drug Sales; 3-Month Recordings

The Union Health Ministry has proposed mandatory CCTV installation at medical stores selling prescription and habit-forming drugs (Schedule H, H1, X) to curb unauthorized sale and drug abuse, especially among children. Chemists oppose citing cost, privacy, and rural connectivity issues. The move involves CDSCO and the Drugs Consultative Committee.

UN High-Level Meeting on Pandemic Preparedness: India Stresses Resilient Health Systems, Pathogen Access Benefit Sharing

India, represented by Union Health Secretary Punya Salila Srivastava, affirmed its commitment to global pandemic preparedness at a UN high-level meeting, emphasizing resilient health systems, digital public infrastructure, and fair access to health products. The article is crucial for aspirants as it ties India's COVID-19 experience to global health security frameworks like the WHO Pandemic Agreement and the Pathogen Access and Benefit Sharing (PABS) system.

India Hits Record 1.37 Lakh MBBS Seats (2026-27); Private Colleges Now Hold 54% Share

India has achieved a record 1,36,939 MBBS seats across 823 medical colleges in 2026-27, marking a 167% increase from 2014-15. For the first time, private colleges hold a majority (54%) of these seats, raising concerns about affordability of medical education.

Health Ministry Amends Drugs Rules, 1945: New Debarment Power for Fake Data Cases

The Health Ministry has strengthened the Drugs Rules, 1945 to penalize applicants who submit fake data for drug approvals. Previously, only rejection/cancellation was possible; now licensing authorities can debar entities from filing new applications for a period, with show-cause notice and appeal provisions. This is crucial for exam questions on regulatory frameworks, pharmaceutical governance, and the Drugs & Cosmetics Act.

FSSAI Tightens Rules on Food Claims: ‘100% Pure’ and Health Labels Under Scrutiny

FSSAI is proposing stricter regulations on food product claims like '100% Pure' and health endorsements, following concerns over misleading marketing—especially for products like Bournvita marketed for children's nutrition. This move aims to protect consumers and enforce honest labeling.

FSSAI Licensing Thresholds Revised: Maharashtra FDA Crackdown Highlights Food Safety Act 2006

Maharashtra FDA commissioner Tukaram Mundhe’s inspection drive has put food safety back in the national spotlight. The article maps the global food-safety framework, India’s FSS Act 2006 and FSSAI, and the implementation gaps—making it directly useful for GS2/GS3 and Prelims facts.

Health Ministry Backs Same-Sex Partners' Medical Decision Rights Under Mental Healthcare Act, 2017

The Union Health Ministry has told the Delhi High Court that excluding same-sex partners from making medical decisions for each other solely based on sexual orientation is unethical. This marks a significant administrative shift, though the government maintains that 'spouse' under Indian marriage laws only applies to heterosexual couples, creating a nuanced legal landscape for exam aspirants.